CXVSPACB• 28 Days (Normalized)
CX vs PACB (Cemex S.A.B. de C.V. Sponsored ADR vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CX Performance $9.59
-11.61%
Cemex S.A.B. de C.V. Sponsored ADR
Normalized Baseline0.00%
PACB Performance $2.72
+110.85%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-122.46 pts
PACB outperforming by 122.46 percentage points
CXPACB
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CX PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | CX Price | CX Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $9.59 | -11.61% | $2.72 | +110.85% | -122.46% |
| Oct 06, 2026 | $9.92 | -8.57% | $2.70 | +109.30% | -117.87% |
| Oct 05, 2026 | $9.54 | -12.07% | $2.87 | +122.48% | -134.55% |
| Oct 02, 2026 | $9.53 | -12.17% | $2.54 | +96.90% | -109.07% |
| Oct 01, 2026 | $9.40 | -13.36% | $2.51 | +94.57% | -107.93% |
| Sep 30, 2026 | $9.51 | -12.35% | $2.37 | +83.72% | -96.07% |
| Sep 29, 2026 | $9.65 | -11.06% | $1.83 | +41.86% | -52.92% |
| Sep 28, 2026 | $9.53 | -12.17% | $1.71 | +32.56% | -44.73% |
| Sep 25, 2026 | $9.71 | -10.51% | $- | - | |
| Sep 24, 2026 | $- | $1.46 | +12.79% | - | |
| Sep 23, 2026 | $9.76 | -10.05% | $1.41 | +9.30% | -19.35% |
| Sep 22, 2026 | $10.24 | -5.62% | $- | - | |
| Sep 21, 2026 | $10.02 | -7.65% | $1.36 | +5.43% | -13.08% |
| Sep 18, 2026 | $10.06 | -7.28% | $1.37 | +6.20% | -13.48% |
| Sep 17, 2026 | $10.19 | -6.08% | $1.38 | +6.98% | -13.06% |
Page 1 of 2